BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 33725979)

  • 1. Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015.
    Kim J; Bae YJ; Lee JW; Kim YS; Kim Y; You HS; Kim HS; Choi EA; Han YE; Kang HT
    Medicine (Baltimore); 2021 Mar; 100(11):e25045. PubMed ID: 33725979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between statin use and all-cause mortality in cancer survivors, based on the Korean health insurance service between 2002 and 2015.
    Kim J; Choi EA; Han YE; Lee JW; Kim YS; Kim Y; You HS; Hyun HJ; Kang HT
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):434-440. PubMed ID: 31831365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
    Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
    Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort.
    Kim YS; Choi EA; Lee JW; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kang HT; Kim J
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1714-1722. PubMed ID: 32753274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin usage and the risk of colorectal cancer: a national cohort study.
    Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
    Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
    Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
    Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin use in elderly population with diabetes reduced the risk of dementia in a dose-dependent manner, based on the Korean NHIS-HEALS cohort.
    Kim Y; Kim HS; Lee JW; Kim YS; You HS; Bae YJ; Lee HC; Han YE; Choi EA; Kim J; Kang HT
    Diabetes Res Clin Pract; 2020 Dec; 170():108496. PubMed ID: 33068660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use increased new-onset diabetes in hypercholesterolemic individuals: Data from the Korean National Health Insurance Service-National Health Screening Cohort database (NHIS-HEALS).
    Kim YS; Han YE; Choi EA; You NY; Lee JW; You HS; Kim Y; Kim J; Kang HT
    Prim Care Diabetes; 2020 Jun; 14(3):246-253. PubMed ID: 31548127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.
    Gong Z; Aragaki AK; Chlebowski RT; Manson JE; Rohan TE; Chen C; Vitolins MZ; Tinker LF; LeBlanc ES; Kuller LH; Hou L; LaMonte MJ; Luo J; Wactawski-Wende J
    Int J Cancer; 2016 Apr; 138(8):1915-27. PubMed ID: 26616262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study.
    Park JY; Lim MC; Baek MH; Park YH; Kim S
    J Gynecol Oncol; 2021 Jul; 32(4):e65. PubMed ID: 34085799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
    Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
    Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Use May Increase Risk of Pancreatic Cancer in Diabetic Women: An Analysis of the Korean National Health Insurance Service-National Health Screening Cohort Database.
    Kim J; Bae YJ; Kang HT
    Korean J Fam Med; 2022 Sep; 43(5):327-333. PubMed ID: 36168905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.
    Wu H; Walker J; Damhuis RA; Brewster DH; Wild SH;
    Lung Cancer; 2016 Sep; 99():194-9. PubMed ID: 27565939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.